Not an Allergy, but It Looks Like One
Histamine intolerance (HIT) produces symptoms that mimic allergic reactions — flushing, headaches, nasal congestion, urticaria, abdominal cramps, diarrhoea, and even hypotension — but without an IgE-mediated immune mechanism. Instead, HIT arises from an imbalance between histamine accumulation and histamine degradation, most commonly due to reduced activity of the enzyme diamine oxidase (DAO) in the intestinal mucosa.
The Enzyme Bottleneck
DAO is the primary enzyme responsible for degrading ingested histamine in the gut. It is expressed on the apical surface of intestinal epithelial cells and breaks down histamine before it enters systemic circulation. When DAO activity is insufficient — due to genetic polymorphisms (rs10156191, rs1049793), intestinal mucosal damage (IBD, coeliac disease), or DAO-inhibiting medications (cimetidine, chloroquine, aminophylline) — dietary histamine accumulates and produces systemic symptoms.
A second degradation pathway involves histamine N-methyltransferase (HNMT), which operates intracellularly. HNMT handles histamine that has already been absorbed, and polymorphisms affecting its activity may contribute to symptom susceptibility. The interplay between DAO and HNMT activity, histamine production from gut bacteria, and dietary histamine load determines whether the threshold for symptoms is reached.
The Microbial Dimension
Certain gut bacteria produce histamine as a metabolic byproduct. Species including Lactobacillus vaginalis, Morganella morganii, Klebsiella pneumoniae, and Enterobacter aerogenes possess histidine decarboxylase, the enzyme that converts the amino acid histidine into histamine. Conversely, other bacteria degrade histamine or produce anti-inflammatory mediators. Gut dysbiosis that shifts the balance toward histamine-producing species can increase luminal histamine levels, compounding the problem in individuals with marginal DAO activity.
Diagnosis Challenges
There is no universally validated diagnostic test for HIT. Serum DAO levels are commercially available but have limited sensitivity and specificity. Histamine levels in blood are unstable and difficult to measure reliably. In practice, diagnosis relies on clinical history (symptom pattern correlating with histamine-rich food intake), exclusion of true allergy (negative IgE testing), and response to a low-histamine elimination diet followed by controlled reintroduction.
Dietary Management
Histamine-rich foods include aged cheeses, fermented foods (sauerkraut, kimchi, wine, beer), cured meats, smoked fish, vinegar, tomatoes, spinach, and aubergine. Freshness matters: histamine levels in fish and meat increase significantly with storage time, as bacterial histidine decarboxylase acts on the amino acid pool. Management involves reducing dietary histamine load to below the individual's degradation capacity — not eliminating histamine entirely, which is neither necessary nor practical.
Pharmacological Support
DAO enzyme supplements (taken before histamine-rich meals) are available and may reduce symptom burden in some patients, though clinical trial evidence is limited. Antihistamines (H1 blockers such as cetirizine) can manage acute symptoms. Addressing underlying causes of DAO deficiency — treating mucosal inflammation, reviewing DAO-inhibiting medications, and restoring microbial balance — may be more effective long-term than permanent dietary restriction.